← Back to headlines
Analyst Bullish on Beam Therapeutics Over Drug Program Trajectory
An analyst expresses a bullish sentiment on Beam Therapeutics (BEAM) due to the promising trajectory of its drug programs.
19 Feb, 00:39 — 19 Feb, 00:39
Sources
Showing 1 of 1 sources
Related Stories
Athens doctors arrested over death of Greek singer Giorgos Mazonakis
23m ago
Venezuela's Ex-First Lady Cilia Flores Requests Release from US Custody Over Health
29m ago
Israel's Destruction of Hezbollah Tunnels Triggers 4.1 Magnitude Earthquake in Lebanon
42m ago
Several killed in coach crash carrying Dutch tourists in Swiss Alps
45m ago